How a cancer therapy #antibody target was developed and taken to the clinic

antibody, monoclonal, camcertherapy, PierreFabre515H7 mAb, a new monoclonal antibody which blocks SDF-1/CXCR4 signalling for cancer therapy has been explored by Dr Christine Klinguer-Hamour and colleagues at the Centre d'Immunologie Pierre Fabre, and resulted in two mAbs in phase 1 clinical trials.

At the 2011 European Antibody Congress Dr Klinguer-Hamour presented a case study taking the mAb from generation to in vitro studies, binding inhibition assays, and finally clinical studies in animals.

Do you want to see the results ? Click on the video-link below to see the complete presentation!


Do you want to find out more?

Top new results of #antibody therapeutic developments from Dr Janice Reichert

Strategies to enhance #antibody efficacy

How to get #antibodies past the blood-brain barrier

Leave a Reply

Your email address will not be published. Required fields are marked *